Adline Chem Lab has scheduled a meeting of its Board of Directors for August 27, 2026. The gathering will focus on finalizing the Annual General Meeting (AGM) notice for the financial year ended March 31, 2026, and approving key corporate governance documents.

The Board will convene at the company's registered office in Ahmedabad, Gujarat. In addition to the AGM preparations, the directors will consider the appointment of Mrs. Anita Ganeshbhai Marvadi as an Additional Director.

Key Agenda Items

The meeting agenda covers several critical corporate actions required for the ensuing fiscal cycle:

• Approval of the Draft Notice convening the AGM for FY26.
• Endorsement of the Board's Report, including the Management Discussion and Analysis and Corporate Governance Report.
• Determination of the date, time, and mode for the AGM, which may include video conferencing.
• Appointment of a Scrutinizer to oversee the e-voting process.
• Fixing of book closure dates and record dates for determining voting eligibility.

Director Appointment

A significant item on the docket is the proposed appointment of Mrs. Anita Ganeshbhai Marvadi (DIN: 11808366). She is set to join as an Additional Director in the capacity of a Non-Executive Independent Director. This appointment is subject to ratification by the members at the upcoming AGM.

The company, formerly known as Kamron Laboratories Limited, filed the intimation with the BSE Limited on August 24, 2026, pursuant to SEBI Listing Regulations.

Adline Chem Lab Limited reported a return to profitability in its first quarter of FY27, posting a net profit after tax of ₹4.01 lakh for the quarter ended June 30, 2026. This marks a significant turnaround from the net loss of ₹5.13 lakh recorded in the same quarter of the previous fiscal year.

Revenue from operations rose to ₹11.99 lakh, compared to nil revenue reported in Q1FY26. The company’s basic and diluted earnings per share (EPS) were negative at (₹0.17) per equity share of face value ₹10 each, reflecting cumulative losses despite the current quarter's profit.

Financial Performance

The company generated a pre-tax profit of ₹3.20 lakh before exceptional items, up from a loss of ₹5.87 lakh in Q1FY25. For the full financial year ended March 31, 2026, Adline Chem Lab had reported a net loss of ₹28.11 lakh on revenue of ₹1.15 lakh.

What the Numbers Show

A notable divergence exists between the current quarter’s operational performance and the company’s regulatory compliance status. While Adline Chem Lab achieved a pre-tax profit of ₹3.20 lakh, it simultaneously incurred a penalty of ₹1.06 lakh imposed by the BSE for the non-appointment of a Company Secretary during the quarter. This penalty was included in other expenses, indicating that governance costs directly impacted the bottom line even as operational revenues improved.

Governance and Compliance

The unaudited standalone financial results were reviewed by the Audit Committee and approved by the Board of Directors on August 13, 2026. The statutory auditors carried out a limited review of the results, with no qualifications or modifications noted in their report.

The company has not disclosed segment information as Ind AS 108 is not applicable. The figures for the quarter ended March 31, 2026, represent balancing figures between audited full-year data and published year-to-date figures.